News: ISU Iselect Says Outlook For Health Performance In H2 Fy23 Is Unclear At This Point

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 31 (Reuters) - iSelect (ISU) :

    • OUTLOOK FOR HEALTH PERFORMANCE IN H2 FY23 IS UNCLEAR AT THIS POINT
    • FY23 YEAR TO DATE REVENUE BEING APPROXIMATELY 17% LESS THAN REVENUE ACHIEVED DURING SAME PERIOD IN FY22
    • FY23 OVERALL OUTLOOK IS UNCERTAIN
    • OVERALL FINANCIAL PERFORMANCE IN FY23 TO BE SIGNIFICANTLY IMPACTED WHEN COMPARED TO FY22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.